4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 5.08
+0.55 (12.14%)
Jan 16, 2026, 4:18 PM AEST
4DMedical Market Cap
4DMedical has a market cap or net worth of 2.43 billion as of January 16, 2026. Its market cap has increased by 1,128.21% in one year.
Market Cap
2.43B
Enterprise Value
2.42B
Revenue
5.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.08
Market Cap Chart
Since August 7, 2020, 4DMedical's market cap has increased from 420.97M to 2.43B, an increase of 476.42%. That is a compound annual growth rate of 37.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 2.43B | 15.69% |
| Dec 31, 2025 | 2.10B | 961.67% |
| Dec 31, 2024 | 197.57M | -29.31% |
| Dec 29, 2023 | 279.48M | 125.82% |
| Dec 30, 2022 | 123.76M | -68.87% |
| Dec 31, 2021 | 397.56M | -38.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.55B |
| Pro Medicus | 21.90B |
| Cochlear | 17.28B |
| Sonic Healthcare | 11.38B |
| Ramsay Health Care | 8.25B |
| Ansell | 4.82B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |